Posted as supplied by author.

w1. Merck News Release. Merck announces voluntary worldwide withdrawal of VIOXX®. Whitehouse Station, NJ: Merck &Co Inc, 2004. www.vioxx.com/vioxx/documents/english/vioxx_press_release.pdf (accessed 20 May 2005).

w2. Lu L. Statistical review and evaluation. NDA 21-341: Valdecoxib. www.fda.gov/cder/foi/nda/2001/21-341_Bextra_statr_P1.pdf (accessed 20 May 2005).

 
Access jobs at BMJ Careers
Whats new online at Student BMJ